Matrix metalloproteinase-2 proteolyzes mitofusin-2 and impairs mitochondrial function during myocardial ischemia–reperfusion injury

Adebayo M, Singh S, Singh AP, Dasgupta S (2021) Mitochondrial fusion and fission: The fine-tune balance for cellular homeostasis. Faseb J 35:e21620. https://doi.org/10.1096/fj.202100067R

Article  CAS  PubMed  Google Scholar 

Ainbinder A, Boncompagni S, Protasi F, Dirksen RT (2015) Role of Mitofusin-2 in mitochondrial localization and calcium uptake in skeletal muscle. Cell Calcium 57:14–24. https://doi.org/10.1016/j.ceca.2014.11.002

Article  CAS  PubMed  Google Scholar 

Ali MA, Cho WJ, Hudson B, Kassiri Z, Granzier H, Schulz R (2010) Titin is a target of matrix metalloproteinase-2: implications in myocardial ischemia/reperfusion injury. Circulation 122:2039–2047. https://doi.org/10.1161/circulationaha.109.930222

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ali MA, Chow AK, Kandasamy AD, Fan X, West LJ, Crawford BD, Simmen T, Schulz R (2012) Mechanisms of cytosolic targeting of matrix metalloproteinase-2. J Cell Physiol 227:3397–3404. https://doi.org/10.1002/jcp.24040

Article  CAS  PubMed  Google Scholar 

Ali MA, Stepanko A, Fan X, Holt A, Schulz R (2012) Calpain inhibitors exhibit matrix metalloproteinase-2 inhibitory activity. Biochem Biophys Res Commun 423:1–5. https://doi.org/10.1016/j.bbrc.2012.05.005

Article  CAS  PubMed  Google Scholar 

Baines CP, Zhang J, Wang GW, Zheng YT, Xiu JX, Cardwell EM, Bolli R, Ping P (2002) Mitochondrial PKCepsilon and MAPK form signaling modules in the murine heart: enhanced mitochondrial PKCepsilon-MAPK interactions and differential MAPK activation in PKCepsilon-induced cardioprotection. Circ Res 90:390–397. https://doi.org/10.1161/01.res.0000012702.90501.8d

Article  CAS  PubMed  Google Scholar 

Bencsik P, Pálóczi J, Kocsis GF, Pipis J, Belecz I, Varga ZV, Csonka C, Görbe A, Csont T, Ferdinandy P (2014) Moderate inhibition of myocardial matrix metalloproteinase-2 by ilomastat is cardioprotective. Pharmacol Res 80:36–42. https://doi.org/10.1016/j.phrs.2013.12.007

Article  CAS  PubMed  Google Scholar 

Berman HM, Battistuz T, Bhat TN, Bluhm WF, Bourne PE, Burkhardt K, Feng Z, Gilliland GL, Iype L, Jain S, Fagan P, Marvin J, Padilla D, Ravichandran V, Schneider B, Thanki N, Weissig H, Westbrook JD, Zardecki C (2002) The protein data bank. Acta Crystallogr D Biol Crystallogr 58:899–907. https://doi.org/10.1107/s0907444902003451

Article  PubMed  Google Scholar 

Biasini M, Bienert S, Waterhouse A, Arnold K, Studer G, Schmidt T, Kiefer F, Gallo Cassarino T, Bertoni M, Bordoli L, Schwede T (2014) SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res 42:W252-258. https://doi.org/10.1093/nar/gku340

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bøtker HE, Cabrera-Fuentes HA, Ruiz-Meana M, Heusch G, Ovize M (2020) Translational issues for mitoprotective agents as adjunct to reperfusion therapy in patients with ST-segment elevation myocardial infarction. J Cell Mol Med 24:2717–2729. https://doi.org/10.1111/jcmm.14953

Article  PubMed  PubMed Central  Google Scholar 

Bräuninger H, Krüger S, Bacmeister L, Nyström A, Eyerich K, Westermann D, Lindner D (2023) Matrix metalloproteinases in coronary artery disease and myocardial infarction. Basic Res Cardiol 118:18. https://doi.org/10.1007/s00395-023-00987-2

Article  PubMed  PubMed Central  Google Scholar 

Braunwald E, Kloner RA (1985) Myocardial reperfusion: a double-edged sword? J Clin Invest 76:1713–1719. https://doi.org/10.1172/jci112160

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cadete VJ, Arcand SA, Chaharyn BM, Doroszko A, Sawicka J, Mousseau DD, Sawicki G (2013) Matrix metalloproteinase-2 is activated during ischemia/reperfusion in a model of myocardial infarction. Can J Cardiol 29:1495–1503. https://doi.org/10.1016/j.cjca.2013.03.014

Article  PubMed  Google Scholar 

Chan BYH, Roczkowsky A, Cho WJ, Poirier M, Sergi C, Keschrumrus V, Churko JM, Granzier H, Schulz R (2021) MMP inhibitors attenuate doxorubicin cardiotoxicity by preventing intracellular and extracellular matrix remodelling. Cardiovasc Res 117:188–200. https://doi.org/10.1093/cvr/cvaa017

Article  CAS  PubMed  Google Scholar 

Chan BYH, Roczkowsky A, Moser N, Poirier M, Hughes BG, Ilarraza R, Schulz R (2018) Doxorubicin induces de novo expression of N-terminal-truncated matrix metalloproteinase-2 in cardiac myocytes. Can J Physiol Pharmacol 96:1238–1245. https://doi.org/10.1139/cjpp-2018-0275

Article  CAS  PubMed  Google Scholar 

Chen M, He H, Zhan S, Krajewski S, Reed JC, Gottlieb RA (2001) Bid is cleaved by calpain to an active fragment in vitro and during myocardial ischemia/reperfusion. J Biol Chem 276:30724–30728. https://doi.org/10.1074/jbc.M103701200

Article  CAS  PubMed  Google Scholar 

Chen Q, Paillard M, Gomez L, Ross T, Hu Y, Xu A, Lesnefsky EJ (2011) Activation of mitochondrial μ-calpain increases AIF cleavage in cardiac mitochondria during ischemia-reperfusion. Biochem Biophys Res Commun 415:533–538. https://doi.org/10.1016/j.bbrc.2011.10.037

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen Q, Thompson J, Hu Y, Dean J, Lesnefsky EJ (2019) Inhibition of the ubiquitous calpains protects complex I activity and enables improved mitophagy in the heart following ischemia-reperfusion. Am J Physiol Cell Physiol 317:C910-921. https://doi.org/10.1152/ajpcell.00190.2019

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen Y, Csordás G, Jowdy C, Schneider TG, Csordás N, Wang W, Liu Y, Kohlhaas M, Meiser M, Bergem S, Nerbonne JM, Dorn GW 2nd, Maack C (2012) Mitofusin 2-containing mitochondrial-reticular microdomains direct rapid cardiomyocyte bioenergetic responses via interorganelle Ca(2+) crosstalk. Circ Res 111:863–875. https://doi.org/10.1161/circresaha.112.266585

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen Y, Liu Y, Dorn GW 2nd (2011) Mitochondrial fusion is essential for organelle function and cardiac homeostasis. Circ Res 109:1327–1331. https://doi.org/10.1161/circresaha.111.258723

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheung PY, Sawicki G, Wozniak M, Wang W, Radomski MW, Schulz R (2000) Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart. Circulation 101:1833–1839. https://doi.org/10.1161/01.cir.101.15.1833

Article  CAS  PubMed  Google Scholar 

Davidson SM, Ferdinandy P, Andreadou I, Bøtker HE, Heusch G, Ibáñez B, Ovize M, Schulz R, Yellon DM, Hausenloy DJ, Garcia-Dorado D (2019) Multitarget strategies to reduce myocardial ischemia/reperfusion injury: JACC review topic of the week. J Am Coll Cardiol 73:89–99. https://doi.org/10.1016/j.jacc.2018.09.086

Article  PubMed  Google Scholar 

de Brito OM, Scorrano L (2008) Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature 456:605–610. https://doi.org/10.1038/nature07534

Article  CAS  PubMed  Google Scholar 

DeLeon-Pennell KY, Meschiari CA, Jung M, Lindsey ML (2017) Matrix metalloproteinases in myocardial infarction and heart failure. Prog Mol Biol Transl Sci 147:75–100. https://doi.org/10.1016/bs.pmbts.2017.02.001

Article  CAS  PubMed  PubMed Central  Google Scholar 

Disatnik MH, Ferreira JC, Campos JC, Gomes KS, Dourado PM, Qi X, Mochly-Rosen D (2013) Acute inhibition of excessive mitochondrial fission after myocardial infarction prevents long-term cardiac dysfunction. J Am Heart Assoc 2:e000461. https://doi.org/10.1161/jaha.113.000461

Article  PubMed  PubMed Central  Google Scholar 

Dong G, Chen T, Ren X, Zhang Z, Huang W, Liu L, Luo P, Zhou H (2016) Rg1 prevents myocardial hypoxia/reoxygenation injury by regulating mitochondrial dynamics imbalance via modulation of glutamate dehydrogenase and mitofusin 2. Mitochondrion 26:7–18. https://doi.org/10.1016/j.mito.2015.11.003

Article  CAS  PubMed  Google Scholar 

Eckhard U, Huesgen PF, Schilling O, Bellac CL, Butler GS, Cox JH, Dufour A, Goebeler V, Kappelhoff R, Keller UAD, Klein T, Lange PF, Marino G, Morrison CJ, Prudova A, Rodriguez D, Starr AE, Wang Y, Overall CM (2016) Active site specificity profiling of the matrix metalloproteinase family: proteomic identification of 4300 cleavage sites by nine MMPs explored with structural and synthetic peptide cleavage analyses. Matrix Biol 49:37–60. https://doi.org/10.1016/j.matbio.2015.09.003

Article  CAS  PubMed  Google Scholar 

Friedman JR, Lackner LL, West M, DiBenedetto JR, Nunnari J, Voeltz GK (2011) ER tubules mark sites of mitochondrial division. Science 334:358–362. https://doi.org/10.1126/science.1207385

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao CQ, Sawicki G, Suarez-Pinzon WL, Csont T, Wozniak M, Ferdinandy P, Schulz R (2003) Matrix metalloproteinase-2 mediates cytokine-induced myocardial contractile dysfunction. Cardiovasc Res 57:426–433. https://doi.org/10.1016/s0008-6363(02)00719-8

Article  CAS  PubMed  Google Scholar 

Givvimani S, Pushpakumar S, Veeranki S, Tyagi SC (2014) Dysregulation of Mfn2 and Drp-1 proteins in heart failure. Can J Physiol Pharmacol 92:583–591. https://doi.org/10.1139/cjpp-2014-0060

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hausenloy DJ, Botker HE, Engstrom T, Erlinge D, Heusch G, Ibanez B, Kloner RA, Ovize M, Yellon DM, Garcia-Dorado D (2017) Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations. Eur Heart J 38:935–941. https://doi.org/10.1093/eurheartj/ehw145

Article  CAS  PubMed  Google Scholar 

Hom J, Sheu SS (2009) Morphological dynamics of mitochondria–a special emphasis on cardiac muscle cells. J Mol Cell Cardiol 46:811–820. https://doi.org/10.1016/j.yjmcc.2009.02.023

Article  CAS 

Comments (0)

No login
gif